Cross-fostering and improved lactation ameliorates deficits in endocrine pancreatic morphology in growth-restricted adult male rat offspring

Journal of Developmental Origins of Health and Disease

Volumn 1, Issue 4, 2010, Pages 234-244

  Siebel, A L ^a   Gallo, L A ^a   Guan, T C ^a   Owens, J A ^b   Wlodek, M E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

gene expression; nutrition; pancreatic cell

Indexed keywords

EID: 80054885099     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174410000383     Document Type: Article

References (56)

1. Barker, DJP, Osmond, C, Golding, J, Kuh, D, Wadsworth, MEJ. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J. 1989; 298, 564–567.
2. Eriksson, J, Forsen, T, Tuomilehto, J, Osmond, C, Barker, D. Fetal and childhood growth and hypertension in adult life. J Hypertens. 2000; 36, 790–794.
3. McMillen, IC, Robinson, JS. Developmental origins of the metabolic syndrome: prediction, plasticity and programming. Physiol Rev. 2005; 85, 571–633.
4. Simmons, RA, Templeton, LJ, Gertz, SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes. 2001; 50, 2279–2286.
5. Vuguin, P, Raab, E, Liu, B, Barzilai, N, Simmons, RA. Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth-retardation. Diabetes. 2004; 53, 2617–2622.
6. Owens, JA, Gatford, KL, De Blasio, MJ, et-al. Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth. J Physiol. 2007; 584, 935–949.
7. Kahn, BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell. 1998; 92, 593–596.
8. Masiello, P. Animal models of type 2 diabetes with reduced pancreatic β-cell mass. Int J Biochem Cell Biol. 2006; 38, 873–893.
9. Elayat, AA, el Naggar, MM, Tahir, M. An immunocytochemical and morphometric study of the rat pancreatic islets. J Anat. 1995; 186, 629–637.
10. de Lemos, ET, Reis, F, Baptista, S, et-al. Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit. 2007; 13, BR168–BR174.
11. D’Alessandris, C, Lauro, R, Presta, I, Sesti, G. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. 2007; 50, 840–849.
12. Goldberg, RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009; 94, 3171–3182.
13. Siebel, AL, Mibus, A, De Blasio, MJ, et-al. Improved lactational nutrition and postnatal growth ameliorates impairment of glucose tolerance by uteroplacental insufficiency in male rat offspring. Endocrinology. 2008; 149, 3067–3076.
14. Wadley, GD, Siebel, AL, Cooney, GJ, et-al. Uteroplacental insufficiency and reducing litter size alters skeletal muscle mitochondrial biogenesis in a sex specific manner in the adult rat. Am J Physiol. 2008; 294, E861–E869.
15. Wlodek, ME, Ceranic, V, O’Dowd, R, Westcott, KT, Siebel, AL. Maternal progesterone treatment rescues the mammary impairment following uteroplacental insufficiency and improves postnatal pup growth in the rat. Reprod Sci. 2009; 16, 380–390.
16. Schwitzgebel, VM, Somm, E, Klee, P. Modeling intrauterine growth retardation in rodents: impact on pancreas development and glucose homeostasis. Mol Cell Endocrinol. 2009; 304, 78–83.
17. Stoffers, DA, Desai, BM, DeLeon, DD, Simmons, R. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes. 2003; 52, 734–740.
18. Scaglia, L, Cahill, CJ, Finegood, DT, Bonner-Weir, S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997; 138, 1736–1741.
19. Kahn, SE. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab. 2001; 86, 4047–4058.
20. Messer, NA, I’Anson, H. The nature of the metabolic signal that triggers onset of puberty in female rats. Physiol Behav. 2000; 68, 377–382.
21. Gallo, LA, Wlodek, ME, McConell, GK, Laker, RC, Siebel, AL. Exercise training early in life prevents pancreatic β-cell mass deficits in growth restricted male rats. J DOHaD. 2009; 1, S189–S190.
22. Hill, DJ, Hogg, J, Petrik, J, Arany, E, Han, VKM. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas. J Endocrinol. 1999; 160, 305–317.
23. Boujendar, S, Arany, E, Hill, D, Remacle, C, Reusens, B. Taurine supplementation of a low protein diet fed to rat dams normalizes the vascularization of the fetal endocrine pancreas. J Nutr. 2003; 133, 2820–2825.
24. Ham, JN, Crutchlow, MF, Desai, BM, Simmons, RA, Stoffers, DA. Exendin-4 normalizes islet vascularity in intrauterine growth restricted rats: potential role of VEGF. Pediatr Res. 2009; 66, 42–46.
25. Gatford, KL, Mohammad, SNB, Harland, ML, et-al. Impaired b-cell function and inadequate compensatory increases in b-cell mass following intrauterine growth restriction in sheep. Endocrinology. 2008; 149, 5118–5127.
26. Achermann, JC, Hamdani, K, Hindmarsh, C, Brook, CGD. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics. 1998; 102, 345.
27. Sander, M, German, MS. The b cell transcription factors and development of the pancreas. J Mol Med. 1997; 75, 327–340.
28. Ahlgren, U, Jonsson, J, Jonsson, L, Simu, K, Edlund, H. Beta-cell specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 1998; 12, 1763–1769.
29. Chamson-Reig, A, Thyssen, SM, Arany, E, Hill, DJ. Altered pancreatic morphology in the offspring of pregnant rats given reduced dietary protein is time and gender specific. J Endocrinol. 2006; 191, 83–92.
30. Kiraly, MA, Bates, HE, Kaniuk, NA, et-al. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol. 2008; 294, E271–E283.
31. Kubota, N, Tobe, K, Terauchi, Y, et-al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 2000; 49, 1880–1889.
32. Ohneda, M, Inman, LR, Unger, RH. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia. 1995; 38, 173–179.
33. Tanaka, Y, Gleason, CE, Tran, PO, Harmon, JS, Robertson, RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci. 1999; 96, 10857–10862.
34. Wlodek, ME, Mibus, A, Tan, A, et-al. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol. 2007; 18, 1688–1696.
35. O’Dowd, R, Kent, JC, Moseley, JM, Wlodek, ME. Effects of uteroplacental insufficiency and reducing litter size on maternal mammary function and postnatal offspring growth. Am J Physiol. 2008; 294, R539–R548.
36. Wlodek, ME, Westcott, KT, O’Dowd, R, et-al. Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP. Am J Physiol. 2005; 288, R1620–R1627.
37. Di Nicolantonio, R, Koutsis, K, Westcott, KT, Wlodek, ME. Lack of evidence for a role for either the in utero or suckling periods in the exaggerated salt preference of the spontaneously hypertensive rats. Physiol Behav. 2005; 86, 500–507.
38. Di Nicolantonio, R, Koutsis, K, Westcott, KT, Wlodek, ME. Relative contribution of the prenatal versus postnatal period on development of hypertension and growth rate of the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 2006; 33, 9–16.
39. Wlodek, ME, Westcott, KT, Serruto, A, et-al. Impaired mammary function and parathyroid hormone-related protein during lactation in growth-restricted spontaneously hypertensive rats. J Endocrinol. 2003; 177, 233–245.
40. Bonner-Weir, S. β-cell turnover: its assessment and implications. Diabetes. 2001; 50, S20–S24.
41. Wlodek, ME, Westcott, K, Siebel, AL, Owens, JA, Moritz, KM. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int. 2008; 74, 187–195.
42. Ackermann, AM, Gannon, M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007; 38, 193–206.
43. Edlund, H. Pancreatic organogenesis – developmental mechanisms and implications for therapy. Nat Rev Genet. 2002; 3, 524–532.
44. Eriksson, JG, Forsen, T, Tuomilehto, J, Osmond, C, Barker, DJ. Early adiposity rebound in childhood and risk of type 2 diabetes in adult life. Diabetologia. 2003; 46, 190–194.
45. Lucas, A, Fewtrell, MS, Davies, PS, et-al. Breastfeeding and catch-up growth in infants born small for gestational age. Acta Paediatr. 1997; 86, 564–569.
46. Barker, DJP, Osmond, C, Forsen, TJ, Kajantie, E, Eriksson, JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med. 2005; 353, 1802–1809.
47. Parsons, TJ, Power, C, Manor, O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study. BMJ. 2001; 323, 1331–1335.
48. De Blasio, MJ, Gatford, KL, McMillen, IC, Robinson, JS, Owens, JA. Placental restriction of fetal growth increases insulin action, growth and adiposity in the young lamb. Endocrinology. 2007; 148, 1350–1358.
49. Lane, RH, Chandorkar, AK, Flozak, AS, Simmons, RA. Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle. Pediatr Res. 1998; 43, 563–570.
50. Holemans, K, Aerts, L, Van Assche, FA. Lifetime consequences of abnormal fetal pancreatic development. J Physiol. 2003; 547, 11–20.
51. De Prins, FA, Van Assche, FA. Intrauterine growth retardation and development of endocrine pancreas in the experimental rat. Biol Neonate. 1982; 41, 16–21.
52. Ogata, ES, Bussey, ME, Finley, S. Altered gas exchange, limited glucose and branched chain amino acids, and hypoinsulinism retard fetal growth in the rat. Metabolism. 1986; 35, 970–977.
53. Garofano, A, Czernichow, P, Breant, B. In utero undernutrition impairs rat beta-cell development. Diabetologia. 1997; 40, 1231–1234.
54. Lesage, J, Blondeau, B, Grino, M, Breant, B, Dupouy, JP. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 2001; 142, 1692–1702.
55. Park, JH, Stoffers, DA, Nicholls, RD, Simmons, RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008; 118, 2316–2324.
56. Magee, TR, Han, G, Cherian, B, et-al. Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am J Obstet Gynecol. 2008; 199, 271–275.